| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6.9M | -27.9% | -57.4% |
| SG&A Expense | $4.8M | -4.3% | -15.9% |
| Operating Income | -$11.7M | +19.8% | +46.6% |
| Income Tax | $0 | — | — |
| Net Income | -$11.2M | +18.1% | +44.7% |
| EPS (Basic) | -$1.53 | +18.2% | +45.0% |
| EPS (Diluted) | -$1.53 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.9M | +13.3% | +11.7% |
| Short-term Investments | $51.3M | -22.9% | -54.8% |
| Current Assets | $94.5M | -9.7% | -39.6% |
| Total Assets | $97.7M | -10.4% | -40.4% |
| Current Liabilities | $13.4M | -6.9% | -34.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$39.8M | — | — |
| Capital Expenditures | $8K | — | — |
| Investing Cash Flow | $40.9M | — | — |
| Financing Cash Flow | -$3.9M | — | — |
| Free Cash Flow | -$39.8M | — | — |
| +45.0% |
| $1.4M |
| -47.7% |
| -86.6% |
| Total Liabilities | $14.8M | -14.9% | -50.9% |
| Stockholders' Equity | $83.0M | -9.6% | -38.1% |